BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Genisphere Reports Safety of 3DNA Nanocarrier

  The study demonstrated no adverse clinical findings after repeated intravenous administration of the maximum achievable dose of 3DNA nanocarrier.

  November 14, 2017

   · 

  3 min read
• Business

  Albireo Reports Third Quarter 2017 Financial Results

  Albireo reported a net loss of $6.5 million for the third quarter of 2017 compared with a net loss of $4.0 million for the third quarter of 2016.

  November 14, 2017

   · 

  13 min read
• Deals

  Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization

  The acquisition strengthens and expands Quotient’s formulation and manufacturing services footprint in the U.K., and further supports the growth of Quotient’s Translational Pharmaceutics® platform,

  November 14, 2017

   · 

  1 min read
• CEVEC Has Been Granted a New CAPGo Technology Patent And Reinforces its Leading Role in Production of Recombinant Proteins Previously Out of Reach

  The patent broadly protects genetically engineered cell lines for the production of O-glycosylated proteins with a significantly improved plasma half-life.

  November 14, 2017

   · 

  3 min read
• BioCapital

  Neuronascent Granted Composition of Matter Patent in Europe for Oral Neuron Regenerative Technology

  The claims cover small molecule candidates and the family around these candidates and their human use, adding to the patent coverage in the US and elsewhere.

  November 14, 2017

   · 

  2 min read
• Pharm Country

  Akers Biosciences’ UK Distributor Secures New Channel for Rapid Alcohol Breathalyzer

  The BreathScan Alcohol Detector is a proprietary, single-use, non-mechanical device that measures the user’s blood alcohol concentration in approximately 2 minutes, through a simple breath test.

  November 14, 2017

   · 

  4 min read
• Business

  PositiveID Reports Third Quarter 2017 Results; Revenues increase 38% Year over Year

  Company also improves operating results, reducing operating loss 74% for the third quarter of 2017 from the third quarter of 2016.

  November 14, 2017

   · 

  7 min read
• 

  Biotech Bay

  Bay Area’s EBR Systems Scores $50M to Complete Global Heart Failure Trial

  The financing was led by Australian private equity firms M.H. Carnegie & Co. and Brandon Capital Partners.

  November 14, 2017

   · 

  5 min read
• Drug Development

  Poseida Therapeutics Presents on the Development of Allogeneic and Autologous BCMA-Specific CAR-T Therapies at Precision: Blood Cancer Summit

  The presentation expands on the anti-BCMA CAR-T development programs featuring Poseida’s proprietary piggyBac non-viral gene delivery system and Centyrin binding domain.

  November 14, 2017

   · 

  3 min read
• Business

  Arlington Capital Partners Announces Majority Investment in Grand River Aseptic Manufacturing

  Based in Grand Rapids, MI, GRAM is a leading contract, development and manufacturing organization (“CDMO”) focused on the development, manufacture and finishing of parenteral pharmaceuticals.

  November 14, 2017

   · 

  3 min read